Hikal
Ticker >

Hikal share price

Hikal Ltd.

NSE: HIKAL BSE: 524735 SECTOR: Pharmaceuticals & Drugs  97k   350   48

371.80
-12.05 (-3.14%)
BSE: 04 Nov 03:31 PM

Price Summary

Today's High

₹ 382.9

Today's Low

₹ 367

52 Week High

₹ 410.9

52 Week Low

₹ 260.65

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsWeak
Watch out! The company might not be able to sustain any adverse condition.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 4584.32 Cr.

Enterprise Value

₹ 5378.28 Cr.

No. of Shares

12.33 Cr.

P/E

67.57

P/B

3.84

Face Value

₹ 2

Div. Yield

0.32 %

Book Value (TTM)

₹  96.74

CASH

₹ 20.78 Cr.

DEBT

₹ 814.74 Cr.

Promoter Holding

68.85 %

EPS (TTM)

₹  5.5

Sales Growth

-11.79%

ROE

5.99 %

ROCE

7.82%

Profit Growth

-11.31 %

Add Your Ratio

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.

PE Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

PB Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year-11.79%
3 Year1.23%
5 Year2.34%

Profit Growth

1 Year-11.31%
3 Year-19.48%
5 Year-7.58%

ROE%

1 Year5.99%
3 Year9.72%
5 Year11.02%

ROCE %

1 Year7.82%
3 Year10.5%
5 Year12.02%

Debt/Equity

0.686

Price to Cash Flow

24.56

Interest Cover Ratio

2.6927

CFO/PAT (5 Yr. Avg.)

2.48985784441407

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Sep 2024 68.85 0.00
Jun 2024 68.85 0.00
Mar 2024 68.85 0.00
Dec 2023 68.85 0.00
Sep 2023 68.85 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has an efficient Cash Conversion Cycle of 33.8793 days.
  • The company has a good cash flow management; CFO/PAT stands at 2.48985784441407.
  • The company has a high promoter holding of 68.85%.

 Limitations

  • The company has shown a poor profit growth of -19.4783213757201% for the Past 3 years.
  • The company has shown a poor revenue growth of 1.22801855605872% for the Past 3 years.
  • The company is trading at a high PE of 67.57.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024
Net Sales 388 434.88 447.57 514.1 406.8
Total Expenditure 337.7 377.41 382.68 419.75 348.7
Operating Profit 50.3 57.47 64.89 94.35 58.1
Other Income 0.9 0.99 0.06 0.46 0.5
Interest 13.8 13.08 14.24 15.26 19.8
Depreciation 27.7 28.57 28.97 32.34 31.8
Exceptional Items 0 0 0 0 0
Profit Before Tax 9.7 16.81 21.74 47.21 7
Tax 2.8 4.29 5.47 13.35 1.8
Profit After Tax 6.9 12.52 16.27 33.86 5.2
Adjusted EPS (Rs) 0.56 1.02 1.32 2.75 0.42

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 1507.26 1720.44 1942.72 2023.03 1784.6
Total Expenditure 1234.1 1397.55 1602.16 1765.97 1517.65
Operating Profit 273.16 322.89 340.57 257.06 266.95
Other Income 3.7 4.98 4.89 5.41 2.45
Interest 52.42 36.2 31.22 48.1 56.37
Depreciation 82.46 85.25 95.67 109.01 117.61
Exceptional Items -15.4 0 0 0 0
Profit Before Tax 126.58 206.43 218.57 105.36 95.41
Tax 42.14 73.29 58.06 26.98 25.9
Net Profit 84.44 133.14 160.51 78.38 69.51
Adjusted EPS (Rs.) 6.85 10.8 13.02 6.36 5.64

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 24.66 24.66 24.66 24.66 24.66
Total Reserves 791.86 908.76 1043.35 1108.83 1162.93
Borrowings 303.4 262.89 286.68 489.88 422.85
Other N/C liabilities 106.76 116.1 145.22 100.58 120
Current liabilities 652.77 703.3 828.13 661.53 756.62
Total Liabilities 1879.45 2015.71 2328.04 2385.48 2487.07
Assets
Net Block 735.22 712.55 879.46 948.31 1070.63
Capital WIP 152.1 245.39 285.18 402.08 414.34
Intangible WIP 8.71 8.85 9.6 10.08 0
Investments 0.69 0.62 0.65 5.31 5.36
Loans & Advances 148.35 117.82 128.77 75.91 29.15
Other N/C Assets 3.16 5.36 1.13 4.78 1.06
Current Assets 831.22 925.12 1023.25 939.01 966.53
Total Assets 1879.45 2015.71 2328.04 2385.48 2487.07
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations 141.98 206.43 218.57 105.36 95.41
Adjustment 136.17 126.99 126.27 163.13 174.88
Changes in Assets & Liabilities 46.49 -57.9 18.69 75.6 -53.33
Tax Paid -24.31 -46.5 -69.8 -28.8 -30.34
Operating Cash Flow 284.93 229.02 293.73 315.29 186.62
Investing Cash Flow -163.8 -156.2 -284.37 -292.34 -173.75
Financing Cash Flow -100.86 -96.87 -5.56 -7.68 -27
Net Cash Flow 20.27 -24.05 3.8 15.27 -14.12

Corporate Actions

Investors Details

PARTICULARS Sep 2023% Dec 2023% Mar 2024% Jun 2024% Sep 2024%
promoters 68.85 68.85 68.85 68.85 68.85
anika trust 0.06 0.06 0.06 0.06 0.06
anish dilip swadi 0.01 0.01 0.01 0.01 0.01
anish trust 0.06 0.06 0.06 0.06 0.06
ashok vishwanath hiremath... 0.08 0.08 0.08 0.08 0.08
bf investment limited 2.65 2.65 2.65 2.65 2.65
decent electronics pvt lt... 0.04 0.04 0.04 0.04 0.04
ekdant investment pvt ltd... 0.32 0.32 0.32 0.32 0.32
jai v hiremath 1.09 1.09 1.09 1.09 1.09
kalyani investment compan... 31.36 31.36 31.36 31.36 31.36
karad engineering consult... 0.05 0.05 0.05 0.05 0.05
nihal trust 0.06 0.06 0.06 0.06 0.06
pallavi anish swadi 0.31 0.31 0.31 0.31 0.31
pallavi trust 0.15 0.15 0.15 0.15 0.15
pooja hiremath 0.01 0.01 0.01 0.01 0.01
pooja trust 0.06 0.06 0.06 0.06 0.06
rhea trust 0.06 0.06 0.06 0.06 0.06
sameer jai hiremath - - - 0.32 0.32
sameer trust 0.15 0.15 0.15 0.15 0.15
shri badrinath investment... 16.15 16.15 16.15 16.15 16.15
shri rameshwara investmen... 7.96 7.96 7.96 7.96 7.96
sugandha j hiremath - - - 7.84 7.84
sumer trust 0.06 0.06 0.06 0.06 0.06
sameer hiremath 0.32 0.32 0.32 - -
sugandha jai hiremath 7.84 7.84 7.84 - -
PARTICULARS Sep 2023% Dec 2023% Mar 2024% Jun 2024% Sep 2024%
investors 31.15 31.15 31.15 31.15 31.15
government pension fund g... 2.06 2.71 2.71 2.71 2.51
investor education and pr... 0.22 0.22 0.23 - 0.23
llp 0.35 0.28 0.10 0.13 0.13
tata mutual fund - tata s... 2.68 2.68 2.68 2.68 2.68
theleme india master fund... 1.05 1.33 1.64 1.69 1.69
investor education and pr... - - - 0.23 -

Annual Reports

Ratings & Research Reports

Company Presentations

Company News

Hikal - Quaterly Results1 Aug 2024, 2:48PM Hikal - Quaterly Results1 Aug 2024, 2:48PM Hikal - Quaterly Results1 Aug 2024, 2:48PM HIKAL informs about disclosure22 Jul 2024, 2:56PM Hikal informs about closure of trading window26 Jun 2024, 2:02PM Hikal - Quaterly Results9 May 2024, 3:25PM Hikal - Quaterly Results9 May 2024, 3:25PM Hikal - Quaterly Results9 May 2024, 3:25PM Hikal informs about certificate23 Apr 2024, 3:47PM Hikal informs about disclosure23 Feb 2024, 2:33PM Hikal - Quaterly Results8 Feb 2024, 8:10PM Hikal - Quaterly Results8 Feb 2024, 8:10PM Hikal informs about disclosure6 Jan 2024, 12:55PM HIKAL informs about disclosure29 Dec 2023, 4:45PM Hikal - Quaterly Results2 Nov 2023, 2:57PM Hikal - Quaterly Results2 Nov 2023, 2:57PM Hikal - Quaterly Results2 Nov 2023, 2:57PM Hikal informs about press release31 Aug 2023, 3:32PM Hikal - Quaterly Results8 Aug 2023, 3:14PM Hikal - Quaterly Results8 Aug 2023, 3:14PM Hikal - Quaterly Results8 Aug 2023, 3:14PM Hikal - Quaterly Results29 May 2023, 4:11PM Hikal - Quaterly Results29 May 2023, 4:11PM Hikal - Quaterly Results29 May 2023, 4:11PM Hikal informs about board meeting22 May 2023, 4:17PM Hikal informs about press release15 May 2023, 11:57AM USFDA inspects Hikal’s pharmaceutical manufacturing facility at Panoli15 May 2023, 10:41AM Hikal informs about press release 2 Feb 2023, 4:24PM Hikal - Quaterly Results2 Feb 2023, 3:07PM Hikal - Quaterly Results2 Feb 2023, 3:07PM Hikal - Quaterly Results2 Feb 2023, 3:07PM Hikal informs about analyst meet intimation30 Jan 2023, 4:16PM Hikal acquires stakes in Radiance MH Sunrise Two, Radiance MH Sunrise Four13 Dec 2022, 11:59AM Hikal informs about disclosure of related party transactions19 Nov 2022, 11:09AM Hikal informs about transcript of the earnings call16 Nov 2022, 4:28PM Hikal informs about press release9 Nov 2022, 5:01PM Hikal - Quaterly Results9 Nov 2022, 2:03PM Hikal - Quaterly Results9 Nov 2022, 2:03PM Hikal - Quaterly Results9 Nov 2022, 2:03PM Hikal informs about annual report27 Aug 2022, 12:41PM Hikal informs about AGM 27 Aug 2022, 12:33PM Hikal informs about transcript of the earnings call19 Aug 2022, 12:37PM Hikal - Quaterly Results10 Aug 2022, 4:46PM Hikal - Quaterly Results10 Aug 2022, 4:46PM Hikal - Quaterly Results10 Aug 2022, 4:46PM Hikal informs about conference call9 Aug 2022, 3:24PM Hikal gets MPCB’s permission to re-start manufacturing activities at Taloja Plant 30 Jun 2022, 2:25PM Bombay High Court directs MPCB to grant permission to Hikal to re-start Taloja manufacturing activities27 Jun 2022, 4:45PM Hikal reports 59% fall in Q4 net profit 30 May 2022, 3:35PM Hikal - Quaterly Results28 May 2022, 7:24PM

Hikal Stock Price Analysis and Quick Research Report. Is Hikal an attractive stock to invest in?

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Hikal and its performance over the period of time. Hikal stock price today is Rs 369.9.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Hikal cash from the operating activity was Rs 186.624 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Hikal has a Debt to Equity ratio of 0.686 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Hikal , the EPS growth was -11.3083 % which is bad for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Hikal has OPM of 14.9583660203967 % which is a bad sign for profitability.
     
  • ROE: Hikal have a poor ROE of 5.9895 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Hikal is Rs 369.9. One can use valuation calculators of ticker to know if Hikal share price is undervalued or overvalued.
Last Updated on:
Brief about Hikal

Hikal Ltd. Financials: Check Share Price, Balance Sheet, Annual Report, Quarterly Results, Shareholding, Company Profile and News for Company Analysis

Hikal Ltd. is a leading Indian chemical manufacturer with a global footprint. The company was established in 1988 and is headquartered in Bangalore, India. Hikal has a strong presence in the pharmaceutical, crop protection, and specialty chemicals markets and has numerous manufacturing facilities across India, Europe, and the USA. The company is committed to sustainable growth and innovation while maintaining a high level of social and environmental responsibility.

Hikal Ltd. Share Price

Hikal Ltd. is a publicly traded company on the National Stock Exchange (NSE) and the Bombay Stock Exchange (BSE) in India. The share price of Hikal can be tracked on our website's stock analysis page. Our pre-built screening tools provide a real-time view of the company's share price movement and allow investors to track the stock's performance over time.

Hikal Ltd. Balance Sheet

A company's balance sheet is a snapshot of a company's financial position at a given point in time. Hikal Ltd.'s balance sheet can be found on our website, alongside our premium feature tools used for fair value calculation, including DCF Analysis, BVPS Analysis, Earnings multiple approach, and DuPont analysis. Our premium tools allow investors to do a deep dive and better understand Hikal's financial position.

Hikal Ltd. Annual Report

The annual report is an important document that provides insights into a company's performance over the year. Hikal's annual reports are available for download on our website's stock analysis page. The reports include information on the company's revenue, earnings, and overall performance, providing investors with a comprehensive understanding of Hikal's operations.

Hikal Ltd. Dividend

Hikal Ltd.'s dividend history can be found on our website's stock analysis page. Tracking a company's dividend history is important for investors who seek long-term investments as dividends are an important source of income. Our pre-built screening tools provide relevant metrics on dividend yield, payout history, and dividend growth, allowing investors to make informed decisions on Hikal Ltd.

Hikal Ltd. Quarterly Result

The quarterly results of Hikal Ltd. are available for download on our website. The reports include information on the company's revenue, earnings, and overall performance for a particular quarter. Our premium feature tools, such as DCF Analysis, BVPS Analysis, Earnings multiple approach, and DuPont analysis, allow investors to delve deeper into Hikal's quarterly results and make more informed decisions.

Hikal Ltd. Stock Price

Tracking the stock price of a company is important for investors who seek long-term investments. Our pre-built screening tools on the Hikal Ltd. stock analysis page provide real-time updates on the company's stock price movement, high and low trading volumes, and relative strength indicators.

Hikal Ltd. Price Chart

Our website's stock analysis page features the price charts of Hikal Ltd. The price charts track the company's price trend over the years, allowing investors to identify long-term price trends and patterns. It is important for investors to understand price movements before making investment decisions.

Hikal Ltd. News

Our website's stock analysis page offers up-to-date news articles related to Hikal Ltd. News articles include company announcements, industry news, and market updates that may impact Hikal Ltd's share price. Investors can stay informed on the latest news related to Hikal Ltd. and make informed investment decisions.

Hikal Ltd. Concall Transcripts

Hikal Ltd.'s concall transcripts provide investors with detailed information on the company's earnings and performance. Our website provides downloadable concall transcripts for Hikal Ltd. that allow investors to read through a transcript of the analyst call. The transcripts are helpful for investors who want to understand the analyst's queries related to the company's earnings and operations.

Hikal Ltd. Investor Presentations

Hikal Ltd.'s investor presentations are available for download on our website's stock analysis page. Investor presentations provide valuable insights into a company's operations, growth plans, and financial performance. Our website offers a complete set of investor presentations, which are essential for investors seeking a comprehensive understanding of Hikal's business.

Hikal Ltd. Promoters

Hikal Ltd.'s promoters are the individuals or entities that are responsible for the overall management and strategic vision of the company. Our website's stock analysis page provides information related to Hikal Ltd.'s shareholders, ownership structure, and promoter holdings.

Hikal Ltd. Shareholders

Shareholders are important stakeholders in a company, and their investment decisions can impact the company's operations. Our website's stock analysis page provides information on Hikal Ltd.'s shareholders, including institutional and retail investors. Understanding shareholder patterns and trends can help investors make informed investment decisions.

Overall, our website's stock analysis page provides investors with a comprehensive set of tools to analyze Hikal Ltd. and make informed investment decisions. Our pre-built screening tools provide real-time updates on the company's stock price, dividend history, and other relevant metrics, while our premium features allow investors to perform a deep dive analysis of Hikal Ltd's financial position.

Read More
X